Crossref
journal-article
Springer Science and Business Media LLC
European Journal of Pediatrics (297)
References
16
Referenced
43
-
Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutmann L, Buckley RH (1981) Fungal infection in chronic granulomatous disease. Am J Med 71:59–62
(
10.1016/0002-9343(81)90259-X
) / Am J Med by MS Cohen (1981) -
Ezekowitz A (1991) Interferon gamma for chronic granulomatous disease. N Engl J Med 325:1516
(
10.1056/NEJM199111213252115
) / N Engl J Med by A Ezekowitz (1991) -
Ezekowitz RAB, Dinauer MC, Jaffe HS, Orkin SH, Newburger PE (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 319:146–151
(
10.1056/NEJM198807213190305
) / N Engl J Med by RAB Ezekowitz (1988) -
Ezer G, Soothill J (1974) Intracellular bactericidal effects of rifampicin in both normal and chronic granulomatous disease polymorphs. Arch Dis Child 4:463–466
(
10.1136/adc.49.6.463
) / Arch Dis Child by G Ezer (1974) -
Hoger PH, Seger RA, Schaad UB, Hitzig WH (1985) Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes. Pediatr Res 19:38–44
(
10.1203/00006450-198501000-00011
) / Pediatr Res by PH Hoger (1985) -
Huizinga TWJ, Van der Schoot CE, Roos D, Weening RS (1991) Induction of neutrophil FC-γ receptor 1 expression can be used as a marker for biologic activity of recombinant interferon-γ in vivo. Blood 77:2088–2090
(
10.1182/blood.V77.9.2088.2088
) / Blood by TWJ Huizinga (1991) -
The International Chronic Granulomatous Disease Cooperative Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509–516
(
10.1056/NEJM199102213240801
) / N Engl J Med by The International Chronic Granulomatous Disease Cooperative Group (1991) -
Margolis DM, Melwick DA, Alling DW, Gallin JL (1990) Trimethoprim-sulfamethoxazole phrophylaxis in the management of chronic granulomatous disease. J Inf Dis 162:723–726
(
10.1093/infdis/162.3.723
) / J Inf Dis by DM Margolis (1990) -
Mouy R, Fischer A, Vilmer E, Seger R, Grisecelli C (1989) Incidence, severity and prevention of infections in chronic granulomatous disease. J Pediatr 114:555–560
(
10.1016/S0022-3476(89)80693-6
) / J Pediatr by R Mouy (1989) -
Mouy R, Seger R, Bourquin JP, Veber F, Blanche S, Griscelli C, Fischer A (1991) Interferon gamma for chronic granulomatous disease. N Engl J Med 325:1516–1516
(
10.1056/NEJM199111213252115
) / N Engl J Med by R Mouy (1991) -
Muhlebach TJ, Gabay J, Nathan CF, Erny C, Dopfer G, Schroten H, Wahn V, Seger RA (1992). Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four antimicrobial proteins. Clin Exp Immunol 88:203–206
(
10.1111/j.1365-2249.1992.tb03062.x
) / Clin Exp Immunol by TJ Muhlebach (1992) -
Sechler JMG, Malech HL, White CJ, Gallin JL (1988) Recombinant human interferon-g reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci USA 85:4874–4878
(
10.1073/pnas.85.13.4874
) / Proc Natl Acad Sci USA by JMG Sechler (1988) -
Segal AW (1989) The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 83:1785–1793
(
10.1172/JCI114083
) / J Clin Invest by AW Segal (1989) - Seger R, Baumgartner S, Tiefenauer L, Gmunder F (1981) Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function. Helv Paediatr Acta 36:579–588 / Helv Paediatr Acta by R Seger (1981)
-
Weening RS, Kabel P, Pijman P, Roos D (1983) Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr 103:127–130
(
10.1016/S0022-3476(83)80798-7
) / J Pediatr by RS Weening (1983) -
Woodman RC, Erickson RW, Rea J, Jaffe HS, Curnutte JT (1992) Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood 79:1558–1562
(
10.1182/blood.V79.6.1558.1558
) / Blood by RC Woodman (1992)
Dates
Type | When |
---|---|
Created | 20 years, 1 month ago (Aug. 2, 2005, 3:04 a.m.) |
Deposited | 5 years, 4 months ago (April 8, 2020, 10:57 a.m.) |
Indexed | 2 months ago (June 30, 2025, 7:27 a.m.) |
Issued | 31 years, 10 months ago (Nov. 1, 1993) |
Published | 31 years, 10 months ago (Nov. 1, 1993) |
Published Print | 31 years, 10 months ago (Nov. 1, 1993) |
@article{Fischer_1993, title={The management of chronic granulomatous disease}, volume={152}, ISSN={1432-1076}, url={http://dx.doi.org/10.1007/bf01957525}, DOI={10.1007/bf01957525}, number={11}, journal={European Journal of Pediatrics}, publisher={Springer Science and Business Media LLC}, author={Fischer, A. and Segal, A. W. and Seger, R. and Weening, R. S.}, year={1993}, month=nov, pages={896–899} }